Merck & Company (6MK) Q2 2026 Earnings Report
CH:6MK Q2 2026 EPS Results
- Actual EPS
- -CHF 0.11
- Consensus EPS
- -CHF 0.22
- Beat/Miss
- Beat by +CHF 0.12
- One Year Ago EPS
- CHF 1.75
CH:6MK Q2 2026 Revenue Results
- Actual Revenue
- CHF 13.66B
- Expected Revenue
- CHF 13.49B
- Beat/Miss
- Beat by +CHF 173.89M
- YoY Revenue Growth
- +4.94%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/04/2026
- Time
- Before Open
- Conference Call
- Tuesday, August 4, 2026
CH:6MK Upcoming Earnings
Merck & Company's next earnings date is estimated for February 2, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:6MK Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:6MK Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 02, 2027 | 2026 (Q4) | 1.48- | 1.68 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 1.722.05 | 2.13 | -3.49% (-0.07) | |
| Aug 04, 2026 | 2026 (Q2) | -0.22-0.11 | 1.75 | -106.10% (-1.86) | |
| Apr 30, 2026 | 2026 (Q1) | -1.21-1.05 | 1.83 | -157.66% (-2.88) | |
| Feb 03, 2026 | 2025 (Q4) | 1.661.68 | 1.42 | 18.60% (+0.26) | |
| Oct 30, 2025 | 2025 (Q3) | 1.952.13 | 1.29 | 64.33% (+0.83) | |
| Jul 30, 2025 | 2025 (Q2) | 1.671.75 | 1.88 | -6.58% (-0.12) | |
| Apr 24, 2025 | 2025 (Q1) | 1.761.83 | 1.71 | 7.25% (+0.12) | |
| Feb 04, 2025 | 2024 (Q4) | 1.331.42 | 0.02 | 5633.33% (+1.39) | |
| Oct 31, 2024 | 2024 (Q3) | 1.221.29 | 1.75 | -26.29% (-0.46) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed